QSAR and 3D QSAR in drug design .1. methodology

被引:309
|
作者
Kubinyi, H
机构
[1] Drug Design, ZHV/W-A30, BASF AG
关键词
D O I
10.1016/S1359-6446(97)01079-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Classical QSAR methods describe structure-activity relationships in terms of physicochemical parameters and steric properties (Hansch analysis, extrathermodynamic approach), or certain structural features (Free Wilson analysis). 3D QSAR methods, especially comparative molecular field analysis, consider the three-dimensional structures and the binding modes of protein ligands. Quantitative similarity-activity relationships derive correlations between the similarities of individual compounds and their biological activities. Theory and methodology of these approaches are described here, together with the proper use of regression and partial least squares analyses for deriving quantitative structure-activity relationships. Part 2, to be published in the December issue, will address applications and problems.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 50 条
  • [1] QSAR and 3D QSAR in drug design .2. Applications and problems
    Kubinyi, H
    DRUG DISCOVERY TODAY, 1997, 2 (12) : 538 - 546
  • [2] 3D QSAR in drug design: Recent advances - Preface
    Kubinyi, H
    Folkers, G
    Martin, YC
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1998, 12 : V - VII
  • [3] QSAR, 3D QSAR and beyond.
    Kubinyi, H
    Sadowski, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U667 - U667
  • [4] 3D-QSAR in Drug Design - A Review
    Verma, Jitender
    Khedkar, Vijay M.
    Coutinho, Evans C.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (01) : 95 - 115
  • [5] PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
    Dixon, Steven L.
    Smondyrev, Alexander M.
    Knoll, Eric H.
    Rao, Shashidhar N.
    Shaw, David E.
    Friesner, Richard A.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (10-11) : 647 - 671
  • [6] PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
    Steven L. Dixon
    Alexander M. Smondyrev
    Eric H. Knoll
    Shashidhar N. Rao
    David E. Shaw
    Richard A. Friesner
    Journal of Computer-Aided Molecular Design, 2006, 20 : 647 - 671
  • [7] QSAR AND DRUG DESIGN
    TUTE, M
    CHEMISTRY & INDUSTRY, 1983, (01) : 10 - 13
  • [8] QSAR and 3D QSAR of inhibitors of the epidermal growth factor receptor
    Pinto-Bazurco, M
    Tsakovska, I
    Pajeva, I
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2006, 106 (06) : 1432 - 1444
  • [9] Neural networks in 3D QSAR
    Livingstone, DJ
    Manallack, DT
    QSAR & COMBINATORIAL SCIENCE, 2003, 22 (05): : 510 - 518
  • [10] Multiway calibration in 3D QSAR
    Nilsson, J
    DeJong, S
    Smilde, AK
    JOURNAL OF CHEMOMETRICS, 1997, 11 (06) : 511 - 524